Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project
Top Cited Papers
Open Access
- 27 April 2017
- journal article
- Published by American Society of Hematology in Blood
- Vol. 129 (17), 2368-2374
- https://doi.org/10.1182/blood-2016-02-683169
Abstract
Key Points Bleeding in US hemophilia patients has decreased dramatically in parallel with increased use of prophylaxis. Only prophylaxis started before age 4 years preserves normal joint function.This publication has 18 references indexed in Scilit:
- Factors affecting the Haemophilia Joint Health Score in children with severe haemophiliaHaemophilia, 2013
- Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)Journal of Thrombosis and Haemostasis, 2013
- Prevalence of depression in adults with haemophiliaHaemophilia, 2012
- Physical Functioning in Boys with Hemophilia in the U.S.American Journal of Preventive Medicine, 2011
- Psychosocial aspects of haemophilia: a systematic review of methodologies and findingsHaemophilia, 2011
- The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia AHaemophilia, 2011
- Blood‐induced joint disease: the pathophysiology of hemophilic arthropathyJournal of Thrombosis and Haemostasis, 2010
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaThe New England Journal of Medicine, 2007
- Results of secondary prophylaxis in children with severe hemophiliaAmerican Journal of Hematology, 1994
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994